Literature DB >> 22470100

CYP1A1 is a target of miR-892a-mediated post-transcriptional repression.

Yeong Min Choi1, Sungkwan An, Eun-Mee Lee, Karam Kim, Sung Jin Choi, Ju Sub Kim, Hyun Hee Jang, In-Sook An, Seunghee Bae.   

Abstract

Cytochrome P450 1A1 (CYP1A1) is a member of the cytochrome p450 enzyme family, which is involved in the metabolisms of carcinogenic metabolites, such as benzo(a)pyrene. In this study, we identified miR-892a as a negative regulator of CYP1A1 expression. Luciferase assays revealed a sequence in the 3'-untranslated region of CYP1A1 that displayed a perfect match with miR-892a, and revealed that this sequence was a specific miR-892a target site. The overexpression of miR‑892a inhibited the expression of the CYP1A1 protein, and the miR‑892a antagonist increased CYP1A1 expression. Of note, benzo(a)pyrene, a major inducer of CYP1A1 transcription, decreased the expression of miR-892a. Moreover, the miR-892a-induced CYP1A1 repression inhibited the benzo(a)pyrene-mediated decrease in cell viability. These data provide insight into the CYP1A1 regulatory network.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22470100     DOI: 10.3892/ijo.2012.1418

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  16 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

Review 2.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

3.  Development of a cell line from the American eel brain expressing endothelial cell properties.

Authors:  Sophia R Bloch; Nguyen T K Vo; Sarah K Walsh; Cici Chen; Lucy E J Lee; Peter V Hodson; Niels C Bols
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-12-29       Impact factor: 2.416

Review 4.  Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review.

Authors:  Grace Chappell; Igor P Pogribny; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2016-03-31       Impact factor: 5.657

5.  Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis.

Authors:  Dongying Li; William H Tolleson; Dianke Yu; Si Chen; Lei Guo; Wenming Xiao; Weida Tong; Baitang Ning
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2019-07-15       Impact factor: 3.781

Review 6.  Friend or foe: the role of microRNA in chemotherapy resistance.

Authors:  Haoran Li; Burton B Yang
Journal:  Acta Pharmacol Sin       Date:  2013-04-29       Impact factor: 6.150

7.  The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation.

Authors:  Guiyu Xu; Yuxia Cui; Zhenghua Jia; Yunan Yue; Shuixiang Yang
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

Review 8.  MiRNAs and miRNA Polymorphisms Modify Drug Response.

Authors:  Mu-Peng Li; Yao-Dong Hu; Xiao-Lei Hu; Yan-Jiao Zhang; Yong-Long Yang; Chun Jiang; Jie Tang; Xiao-Ping Chen
Journal:  Int J Environ Res Public Health       Date:  2016-11-08       Impact factor: 3.390

Review 9.  Regulation of multidrug resistance by microRNAs in anti-cancer therapy.

Authors:  Xin An; Cesar Sarmiento; Tao Tan; Hua Zhu
Journal:  Acta Pharm Sin B       Date:  2016-12-03       Impact factor: 11.413

10.  Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.

Authors:  Jarkko Soronen; Hannele Yki-Järvinen; You Zhou; Sanja Sädevirta; Antti-Pekka Sarin; Marja Leivonen; Ksenia Sevastianova; Julia Perttilä; Pirkka-Pekka Laurila; Alexander Sigruener; Gerd Schmitz; Vesa M Olkkonen
Journal:  Physiol Rep       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.